Gen-t
PrivateLast Round
Grant
Jun 1, 2025
Total Funding Raised
$3.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gen-t is a biotechnology company that develops a diverse genetic biobank to support genomic research and precision medicine in Brazil.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gen-t Comparables
Compare Gen-t with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galatea Bio Inc. | 79% | |
| UK Biobank | 73% | |
| Variant Bio | 72% | |
Gen-t Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2025 | ||||
| Pre Seed | Oct 15, 2024 | ||||
| Pre Seed | Sep 12, 2022 |
Gen-t Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 52% MoM.
- Jun 1, 2025
Received grant funding from FAPESP.
Gen-t Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gen-t's valuation, stock price, and market status.